Ceftazidime-avibactam: Combination therapy versus monotherapy in the challenge of pneumonia caused by carbapenem-resistant Klebsiella pneumoniae
This research focused on evaluating the clinical results of patients suffering from pneumonia caused by carbapenem-resistant Klebsiella pneumoniae (CRKP), who received treatment with either ceftazidime–avibactam (CZA) alone or in combination with other antibiotics. From January 2020 to December 2023...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-08-01
|
| Serie: | Heliyon |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2405844024117884 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|